© 2016 All rights reserved.
TD Solutions announced today that they have initiated development of Levellor™ HypoSpray Insulin for insulin-dependent diabetics. More than 6 million Americans use insulin in some form and that number will continue to rise.more»
TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative Palm Beach County based women’s healthcare company, today announced that the United States Food and Drug Administration (FDA) has approved IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia (vaginal pain associated with sexual activity), a symptom of vulvar and vaginal atrophy (VVA), due to menopause.more»
Officials at Boca Raton Regional Hospital today announced that it has pared its list of potential strategic partners to two finalists; Baptist Health South Florida and Cleveland Clinic.more»
For the sixth year in a row, Boca Raton Regional Hospital has had the most primary-affiliated physicians of any hospital in Palm Beach County and surpassed all other institutions combined, recognized as “Top Doctors” by Castle Connolly Medical Ltd.more»
Florida Atlantic University and Max Planck Florida Institute for Neuroscience (MPFI) have combined forces to form the first jointly supported position between the two institutions.more»
Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help speed up the development and production of biologic vaccines and drugs at flexible commercialmore»
The biologics industry essentially consists of huge cell farms that harvest biologics synthesized by mammalian or bacterial cells, or—in the case of Dyadic International (OTCQX: DYAI)—fungal cells.more»